International Journal of Cancer Management

Published by: Kowsar

Cancer Induced Infertility and the Role of L-Carnitine: A Review for Possible Future Clinical Applications

Sahar Sahafi 1 , Mahsa Esfahani 1 and Azadeh Moghaddas 2 , *
Authors Information
1 Student of Pharm D, Isfahan University of Medical Sciences, Isfahan, Iran
2 Assistant Professor of Clinical Pharmacy, Department of Clinical Pharmacy, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • International Journal of Cancer Management: December 2017, 10 (12); e9857
  • Published Online: December 31, 2017
  • Article Type: Review Article
  • Received: November 29, 2016
  • Revised: February 22, 2017
  • Accepted: December 20, 2017
  • DOI: 10.5812/ijcm.9857

To Cite: Sahafi S, Esfahani M, Moghaddas A. Cancer Induced Infertility and the Role of L-Carnitine: A Review for Possible Future Clinical Applications, Int J Cancer Manag. 2017 ; 10(12):e9857. doi: 10.5812/ijcm.9857.

Copyright © 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Georgescu ES, Goldberg JM, du Plessis SS, Agarwal A. Present and future fertility preservation strategies for female cancer patients. Obstet Gynecol Surv. 2008;63(11):725-32. doi: 10.1097/OGX.0b013e318186aaea. [PubMed: 18928577].
  • 2. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. CA Cancer J Clin. 2011;61(4):212-36. doi: 10.3322/caac.20121.
  • 3. Critchley HO, Bath LE, Wallace WH. Radiation damage to the uterus -- review of the effects of treatment of childhood cancer. Hum Fertil (Camb). 2002;5(2):61-6. doi: 10.1080/1464727022000198942. [PubMed: 12082209].
  • 4. Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod. 1993;8(12):2080-7. doi: 10.1093/oxfordjournals.humrep.a137985. [PubMed: 8150906].
  • 5. Schilsky RL, Sherins RJ, Hubbard SM, Wesley MN, Young RC, DeVita VT. Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med. 1981;71(4):552-6. doi: 10.1016/0002-9343(81)90205-9. [PubMed: 7282743].
  • 6. Blumenfeld Z. Chemotherapy and fertility. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):379-90. doi: 10.1016/j.bpobgyn.2011.11.008. [PubMed: 22281514].
  • 7. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered?. Lancet Oncol. 2005;6(4):209-18. doi: 10.1016/S1470-2045(05)70092-9. [PubMed: 15811616].
  • 8. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009;27(16):2677-85. doi: 10.1200/JCO.2008.20.1541. [PubMed: 19364965].
  • 9. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, et al. Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2010;28(2):332-9. doi: 10.1200/JCO.2009.24.9037. [PubMed: 19949008].
  • 10. Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006;98(13):890-6. doi: 10.1093/jnci/djj243. [PubMed: 16818852].
  • 11. Green DM, Nolan VG, Kawashima T, Stovall M, Donaldson SS, Srivastava D, et al. Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study. Fertil Steril. 2011;95(6):1922-7. 1927 e1. doi: 10.1016/j.fertnstert.2011.02.002. [PubMed: 21376314].
  • 12. Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013;14(9):873-81. doi: 10.1016/S1470-2045(13)70251-1. [PubMed: 23856401].
  • 13. Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer. 1983;52(6):988-93. doi: 10.1002/1097-0142(19830915)52:6<988::AID-CNCR2820520610>3.0.CO;2-6. [PubMed: 6411321].
  • 14. Wallace WH, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol (R Coll Radiol). 1989;1(2):75-9. doi: 10.1016/S0936-6555(89)80039-1. [PubMed: 2486484].
  • 15. Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma. 1999;33(1-2):65-76. doi: 10.3109/10428199909093726. [PubMed: 10194122].
  • 16. Katoh MA, Cain KT, Hughes LA, Foxworth LB, Bishop JB, Generoso WM. Female-specific dominant lethal effects in mice. Mutat Res. 1990;230(2):205-17. doi: 10.1016/0027-5107(90)90058-C. [PubMed: 2374557].
  • 17. Speiser B, Rubin P, Casarett G. Aspermia following lower truncal irradiation in Hodgkin's disease. Cancer. 1973;32(3):692-8. doi: 10.1002/1097-0142(197309)32:3<692::AID-CNCR2820320323>3.0.CO;2-I. [PubMed: 4726968].
  • 18. Centola GM, Keller JW, Henzler M, Rubin P. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl. 1994;15(6):608-13. [PubMed: 7721664].
  • 19. Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O, et al. Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol. 2001;12(9):1307-11. [PubMed: 11697845].
  • 20. Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol. 1985;21(5):601-5. doi: 10.1016/0277-5379(85)90088-4. [PubMed: 2408897].
  • 21. Moghaddas A, Dashti-Khavidaki S. Potential protective effects of l-carnitine against neuromuscular ischemia-reperfusion injury: From experimental data to potential clinical applications. Clin Nutr. 2016;35(4):783-90. doi: 10.1016/j.clnu.2015.07.001. [PubMed: 26199084].
  • 22. Mongioi L, Calogero AE, Vicari E, Condorelli RA, Russo GI, Privitera S, et al. The role of carnitine in male infertility. Andrology. 2016;4(5):800-7. doi: 10.1111/andr.12191. [PubMed: 27152678].
  • 23. Kobayashi D, Tamai I, Sai Y, Yoshida K, Wakayama T, Kido Y, et al. Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa. Reproduction. 2007;134(5):651-8. doi: 10.1530/REP-06-0173. [PubMed: 17965255].
  • 24. Balercia G, Regoli F, Armeni T, Koverech A, Mantero F, Boscaro M. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril. 2005;84(3):662-71. doi: 10.1016/j.fertnstert.2005.03.064. [PubMed: 16169400].
  • 25. De Rosa M, Boggia B, Amalfi B, Zarrilli S, Vita A, Colao A, et al. Correlation between seminal carnitine and functional spermatozoal characteristics in men with semen dysfunction of various origins. Drugs R D. 2005;6(1):1-9. doi: 10.2165/00126839-200506010-00001. [PubMed: 15801863].
  • 26. Bornman MS, du Toit D, Otto B, Muller ,I, Hurter P, du Plessis DJ. Seminal carnitine, epididymal function and spermatozoal motility. S Afr Med J. 1989;75(1):20-1. [PubMed: 2911777].
  • 27. Cooper TG, Weidner W, Nieschlag E. The influence of inflammation of the human male genital tract on secretion of the seminal markers alpha-glucosidase, glycerophosphocholine, carnitine, fructose and citric acid. Int J Androl. 1990;13(5):329-36. doi: 10.1111/j.1365-2605.1990.tb01040.x. [PubMed: 2283178].
  • 28. Breitkreutz R, Babylon A, Hack V, Schuster K, Tokus M, Bohles H, et al. Effect of carnitine on muscular glutamate uptake and intramuscular glutathione in malignant diseases. Br J Cancer. 2000;82(2):399-403. doi: 10.1054/bjoc.1999.0933. [PubMed: 10646895].
  • 29. Garolla A, Maiorino M, Roverato A, Roveri A, Ursini F, Foresta C. Oral carnitine supplementation increases sperm motility in asthenozoospermic men with normal sperm phospholipid hydroperoxide glutathione peroxidase levels. Fertil Steril. 2005;83(2):355-61. doi: 10.1016/j.fertnstert.2004.10.010. [PubMed: 15705374].
  • 30. Banihani S, Sharma R, Bayachou M, Sabanegh E, Agarwal A. Human sperm DNA oxidation, motility and viability in the presence of L-carnitine during in vitro incubation and centrifugation. Andrologia. 2012;44 Suppl 1:505-12. doi: 10.1111/j.1439-0272.2011.01216.x. [PubMed: 21950483].
  • 31. Banihani S, Agarwal A, Sharma R, Bayachou M. Cryoprotective effect of L-carnitine on motility, vitality and DNA oxidation of human spermatozoa. Andrologia. 2014;46(6):637-41. doi: 10.1111/and.12130. [PubMed: 23822772].
  • 32. Vicari E, La Vignera S, Condorelli R, Calogero AE. Endothelial antioxidant administration ameliorates the erectile response to PDE5 regardless of the extension of the atherosclerotic process. J Sex Med. 2010;7(3):1247-53. doi: 10.1111/j.1743-6109.2009.01420.x. [PubMed: 19674252].
  • 33. Zhou X, Liu F, Zhai S. Effect of L-carnitine and/or L-acetyl-carnitine in nutrition treatment for male infertility: a systematic review. Asia Pac J Clin Nutr. 2007;16 Suppl 1:383-90. [PubMed: 17392136].
  • 34. Okada FK, Stumpp T, Miraglia SM. Carnitine reduces testicular damage in rats treated with etoposide in the prepubertal phase. Cell Tissue Res. 2009;337(2):269-80. doi: 10.1007/s00441-009-0801-2. [PubMed: 19444474].
  • 35. Cabral RE, Okada FK, Stumpp T, Vendramini V, Miraglia SM. Carnitine partially protects the rat testis against the late damage produced by doxorubicin administered during pre-puberty. Andrology. 2014;2(6):931-42. doi: 10.1111/andr.279. [PubMed: 25270029].
  • 36. Dehghani F, Hassanpour A, Poost-Pasand A, Noorafshan A, Karbalay-Doust S. Protective effects of L-carnitine and homogenized testis tissue on the testis and sperm parameters of busulfan-induced infertile male rats. Iran J Reprod Med. 2013;11(9):693-704. [PubMed: 24639808].
  • 37. Zhu B, Zheng YF, Zhang YY, Cao YS, Zhang L, Li XG, et al. Protective effect of L-carnitine in cyclophosphamide-induced germ cell apoptosis. J Zhejiang Univ Sci B. 2015;16(9):780-7. doi: 10.1631/jzus.B1500015. [PubMed: 26365120].
  • 38. Yuncu M, Bukucu N, Bayat N, Sencar L, Tarakcioglu M. The effect of vitamin E and L-carnitine against methotrexate-induced injury in rat testis. Turk J Med Sci. 2015;45(3):517-25. doi: 10.3906/sag-1409-39. [PubMed: 26281314].
  • 39. Mann SS, Hammarback JA. Gene localization and developmental expression of light chain 3: a common subunit of microtubule-associated protein 1A(MAP1A) and MAP1B. J Neurosci Res. 1996;43(5):535-44. doi: 10.1002/(SICI)1097-4547(19960301)43:5&lt;535::AID-JNR3&gt;3.0.CO;2-J. [PubMed: 8833088].
  • 40. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282(33):24131-45. doi: 10.1074/jbc.M702824200. [PubMed: 17580304].
  • 41. Valente G, Morani F, Nicotra G, Fusco N, Peracchio C, Titone R, et al. Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer. Biomed Res Int. 2014;2014:462658. doi: 10.1155/2014/462658. [PubMed: 25136588].
  • 42. Gramignano G, Lusso MR, Madeddu C, Massa E, Serpe R, Deiana L, et al. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition. 2006;22(2):136-45. doi: 10.1016/j.nut.2005.06.003. [PubMed: 16459226].
  • 43. Mantovani G, Maccio A, Madeddu C, Gramignano G, Serpe R, Massa E, et al. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition. 2008;24(4):305-13. doi: 10.1016/j.nut.2007.12.010. [PubMed: 18262758].
  • 44. Waldner R, Laschan C, Lohninger A, Gessner M, Tuchler H, Huemer M, et al. Effects of doxorubicin-containing chemotherapy and a combination with L-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma. J Cancer Res Clin Oncol. 2006;132(2):121-8. doi: 10.1007/s00432-005-0054-8. [PubMed: 16283381].
  • 45. De Grandis D. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review. CNS Drugs. 2007;21 Suppl 1:39-43. discussion 45-6. doi: 10.2165/00023210-200721001-00006. [PubMed: 17696592].
  • 46. Kanter M, Topcu-Tarladacalisir Y, Parlar S. Antiapoptotic effect of L-carnitine on testicular irradiation in rats. J Mol Histol. 2010;41(2-3):121-8. doi: 10.1007/s10735-010-9267-5. [PubMed: 20446105].
  • 47. Yurut-Caloglu V, Caloglu M, Eskiocak S, Tastekin E, Ozen A, Kurkcu N, et al. Comparison of the protective roles of L-carnitine and amifostine against radiation-induced acute ovarian damage by histopathological and biochemical methods. J Cancer Res Ther. 2015;11(2):447-53. doi: 10.4103/0973-1482.146091. [PubMed: 26148616].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments